SchellerB, HennenB, PohlA, SchiefferH, MarkwirthT. Acute and subacute stent occlusion; risk-reduction by ionic contrast media. Eur Heart J. 2001;22:385–91.
6.
SchräderR, I. EschI, EnsslenR, FachWA, MerleH, SchererD, SievertH, SpiesHF, ZeplinH. A Randomized Trial Comparing the Impact of a Nonionic (Iomeprol) Versus an Ionic (Ioxaglate) Low Osmolar Contrast Medium on Abrupt Vessel Closure and Ischemic Complications After Coronary Angioplasty. J Am Coll Cardiol. 1999;33:395–402.
7.
Al Dieri R, BéguinS, HemkerHC. The ionic contrast medium ioxaglate interferes with thrombin-mediated feedback activation of factor V, factor VIII and platelets. J Thromb Haemost. 2003;1:269–74.
8.
JungF, SpitzerSG, PindurG. Effect of an ionic compared to a non-ionic X-ray contrast agent on platelets and coagulation during diagnostic cardiac catheterisation. Pathophysiol Haemost Thromb. 2002;32:121–6.
9.
Declaration of Helsinki, Recommendations guiding doctors in clinical research. Adopted by the World Medical Association in 1964. Wisconsin Medical Journal. 1967;66(1):25–6.
10.
van der ZwetPMJ. An on-line system for the quantitative analysis of coronary arterial segments. Computers in Cardiology. 1990;157–160.
11.
ElkeM. Kontrastmittel in der radiologischen Diagnostik. G. Thieme, Stuttgart. 1992.
12.
HagenG. über die Bewegung des Wassers in langen cylindrischen Röhren, Ann Phys Chem Poggendorf. 1839;46:425–42.
13.
PoiseuilleJML. Recherches sur les causes du mouvement du sang sur les veines. J Physiol Exp Pathol. 1830;10:277–95.
14.
EinsteinA. “über die von der molekularkinetischen Theorie der Wärme geforderte Bewegung von in ruhenden Flüssigkeiten suspendierten Teilchen”. Annalen der Physik. 1905;322:549–60.
15.
JungF, SchmittRM, SchellerB, BachR, HeidtmannD, SpitzerS. H. Flußraten von Röntgenkontrastmitteln verschiedener Viskosität in 4.1-Charrière-Koronarkathetern. Z Kardiologie. 1996;85:537–42.
16.
HermillerJB, CusmaJT, SperoLA, FortinDF, HardingMB, BashoreT. Quantitative and qualitative coronary angiographic analysis: review of methods, utility and limitations. Cathet Cardiovasc Diagn. 1992;25:110–31.
17.
HerringtonDM, SiebesM, SokolDK, SiuCO, WalfordGD. Variability in measures of coronary lumen dimensions using quantitative coronary angiography. J Am Coll Cardiol. 1993;22:1068–74.
18.
LesperanceJ, WatersD. Measuring progression and regression of coronary atherosclerosis in clinical trials: Problems and progress. Int J Card Imaging. 1992;8:165–73.
19.
SchellerB, SpeckU, SchmittA, BöhmM, NickenigG. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. Journal of the American College of Cardiology. 2003;42:1415–20.
20.
SchellerB, SpeckU, AbramjukC, BernhardtU, BöhmM, NickenigG. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810–4.
21.
SpeckU, SchellerB, AbramjukC, et al.Neointima inhibition: Comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology. 2006;240:411–8.
